Skip to content

Verbeeck

Active Private limited companyfounded 1997active for 29 yearsIerlandlaan 5, 2440 GeelKBO/BCE: BE 0461.214.016

Lifetime

20 annual accounts with figures on one time axis, 29 filings since 1997
peak of €549,087 in 2024
€525,779▼ 4.2%
peak of €589,379 in 2025
€589,379▲ 51.1%
peak of €2.0m in 2025
€2.0m▲ 27.3%
€185,822▲ 82.3%
Board2 names since 1997
2 directors and 1 other
Documentsfilings and deeds
09-07-202622 days before the deadline
2025micro format
Result from €390,178 to €589,379Dividend €166,085Equity from €1.6m to €2.0mDebts from €101,905 to €185,822Cash from €243,596 to €937,368

Key points

from the 2025 annual accounts

Equity

€2.0m ▲ 27.3%

Verbeeck has made a profit in every financial year since 2006.

Result

€589,379 ▲ 51.1%
€390,0002024€589,0002025

The result rose in 2025 from €390,178 to €589,379.

Debts

€185,822 ▲ 82.3%
Financial debts
+37,184
Suppliers
+12,158
Taxes and wages
+9,521
The rest
+25,054

Debts rose by €83,916 in 2025.

Investments

€107,871 3.2 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Filings

29 annual accounts since 1997
AprilJune31 JulyOctober200020102020

The last five annual accounts were filed 1 to 27 days before the end of the period.

Position in the sector

€589,379

Higher net result than 95% of companies in human health. The sector median is €59,520, over 21,355 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as Verbeeck has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for Verbeeck. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 04-12-2007
Director

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0461214016
1 director appointed, 1 resignation changes role from manager to director · resigns as statutory director · appointed as statutory director · Gazette deed
reappointed as statutory manager General meeting of 18-07-2017 · Gazette deed
Incorporation published on 05-08-1997 · Gazette deed
All 40 events

Comparable companies

same main activity, similar in size and age
Company
Verbeeck Geel €2.2m €525,779 91.4% -
JUUL BOES Oud-Turnhout €2.1m €524,905 83.0% -
DOKTER A.-M DE COCK Willebroek €2.1m €475,077 94.1% -
Cardiogyn Watermael-Boitsfort €2.2m €505,632 42.0% -
CABINET GYNECO-CHIRURGICAL Uccle €2.4m €537,684 85.5% -
Dr. Van Tendeloo & Dubelloy Lommel €2.2m €591,395 86.9% 1.3
VERBANCK-MALYSSE DOKTERS Ypres €1.9m €566,774 98.9% -

These companies have the same main activity as Verbeeck: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.9m and €2.4m, founded between 1995 and 2000.

Official details

Source: KBO
Status
Active since 24-07-1997Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.301.930.8532440 Geel, since 18-07-1997
Financial year end
31 December
Peppol
Reachable since 02-09-2025
Company details

Annual accounts 2025

≈ €790,000estimated
€2.2m▲ 30.7%
Filing
Filed on 09-07-2026, 22 days before the end of the filing period
Financials

Insights on Verbeeck

Verbeeck files the micro format. That format states no turnover. The gross margin rose from €171,143 in 2006 to €525,779 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Verbeeck

What is the company number of Verbeeck?
The company number of Verbeeck is 0461.214.016. The VAT number is the same number with BE in front: BE 0461.214.016.
Where is Verbeeck based?
The registered office is at Ierlandlaan 5, 2440 Geel.Company details
What does Verbeeck do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Verbeeck?
Verbeeck is a private limited company (BV).
When was Verbeeck founded?
Verbeeck was founded on 24-07-1997.
Is Verbeeck still active?
Yes, Verbeeck is an active enterprise in the KBO register.
What is the turnover of Verbeeck?
The turnover in financial year 2025 is about €790,000. This figure is estimated from the gross margin of €525,779 and 31 comparable companies (NACE 86220). It probably lies between €700,000 and €1.1m.Financials
Is Verbeeck profitable?
In financial year 2025, Verbeeck made a profit of €589,379.
Where can I find the annual accounts of Verbeeck?
Verbeeck filed 29 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Verbeeck due?
Verbeeck must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.